Evidence Level
Ginger has been extensively studied for its therapeutic effects across various health conditions. A meta-analysis by Bartels et al. (2015) involving five randomized controlled trials (n=593) demonstrated that ginger significantly reduces pain in osteoarthritis patients compared to placebo. Furthermore, Jalali et al. (2020) conducted a systematic review of 16 RCTs and found that ginger supplementation leads to significant reductions in inflammatory markers such as CRP, IL-6, and TNF-alpha.
In terms of antiemetic properties, Hu et al. (2022) performed a meta-analysis comparing ginger with vitamin B6 and placebo during pregnancy, concluding that ginger effectively reduces nausea and vomiting. Additionally, Kim et al. (2022) reviewed five RCTs involving breast cancer patients undergoing chemotherapy and found that ginger significantly reduced both acute and delayed chemotherapy-induced nausea and vomiting without serious side effects.
Mechanistically, the active compounds in ginger, including gingerols and shogaols, act as dual COX-2/5-LOX inhibitors, providing broader anti-inflammatory coverage compared to single-pathway agents. The dried or heated form of ginger, which contains higher levels of shogaols, may exhibit greater anti-inflammatory potency than fresh ginger, which is richer in gingerols.
In summary, Ginger has robust evidence supporting its use for pain management, reducing inflammation, and alleviating nausea and vomiting across various conditions.